Introduction {#s1}
============

Cardiovascular disease is one of the main causes of death worldwide, and an important etiology of some morbidity in life. For majority of cardiovascular diseases, early diagnosis (within minutes) and early intervention can be independent outcome defining factors. Expert clinicians and adequate health facilities in the health care center are needed to manage these critical patients \[[@R01]\].

Scoring systems are used to assess disease severity of patients in the critical care unit. This scoring system mainly use the patient's data in the first 24-h period after the patient came to the critical care unit to predict short-term outcome, such as in-hospital mortality rate \[[@R02]\].

Most of the scoring systems used for patient management in the intensive care unit (ICU) are complex and needed to be updated regularly. Acute Physiology and Chronic Health Evaluation (APACHE) and Simplified Acute Physiology Score (SAPS) are two most frequent scoring systems used by clinicians \[[@R02]\]. These scoring systems (APACHE II, IV and SAPS III) have the same sensitivity and specificity in predicting ICU patients mortality \[[@R03]\].

Most of the available scoring systems are used to predict the ICU patients mortality, whereas the scoring systems specifically for cardiovascular intensive care unit (CICU) patients have not yet adequately developed. This is essential as acute coronary syndrome, acute or chronic heart failure, cardiogenic shock, valvular heart disease, arrhythmia and pulmonary embolism highly contribute to mortality rate in the CICU \[[@R02], [@R04]\].

Some predictors included in the APACHE score are comorbidity factors, resuscitation in the beginning of inpatient, the use of mechanic ventilator, and so on \[[@R02]\]. Some studies show that there are other predictors of mortality especially in patients who undergo open heart surgeries; body mass index \> 27 kg/m^2^, glomerulus filtration rate \< 50 mL/min, New York Heart Association (NYHA) class IV heart failure and systolic pulmonary arterial pressure \> 55 mm Hg \[[@R05]\].

The aim of this study is to analyze characteristics that can be used as predictors of mortality which in the future can be developed into a scoring system to predict mortality rate at CICU of Sardjito General Hospital.

Materials and Methods {#s2}
=====================

This is a cross sectional study aiming to analyze factors which can be used to predict patient mortality at CICU and to develop a scoring system subsequently. All patients at CICU of Sardjito General Hospital Yogyakarta were collected consecutively from January until October 2017. Inclusion criteria include study participants aged \> 18 years old and signed a informed consent to participate in the study. Demographic data (age, gender and the patient risk factors), clinical data (patient comorbidities), laboratory examination (routine blood test, renal function, liver function and blood sugar) and echocardiography (ejection fraction and right ventricular function (tricuspid annular plane systolic excursion (TAPSE)) were obtained.

The independent variables in this study are all factors that can predict mortality whilst the dependent variable is mortality regardless the etiology. However, the mortality data are limited by only those happened during treatment at the CICU.

A bivariate analysis was used to analyze the association between predicting factors and mortality. Chi-square test was chosen to analyze the correlation with Fisher's test as an alternative test. Furthermore, a multivariate analysis was undertaken by taking variables in the bivariate analysis with P \< 0.25. Then a logistic regression was used with stepwise backward method. B and SE score from SPSS were then added to scoring system using multivariate analysis. There are two scoring systems derived from this analysis: 1) Probability; and 2) Cut-off scoring system which based on receiver operating characteristic (ROC) curve. The previous scoring system would be validated to some samples to find out their diagnostic value. All data analysis was conducted by SPSS ver.16 program.

Other essential informations needed from the research participants were taken from the medical record or direct anamnesis with the participants. Data sampling was done with non-probability sampling.

Research ethic {#s2a}
--------------

The study was conducted according to the Institutional Review Board guidelines at the Faculty of Medicine, Public Health, and Nursing Universitas Gadjah Mada/Sardjito General Hospital on human subjects, and complies with the Helsinki Declaration. Each participant enrolled in the study has been given a thorough explanation based on informed consent.

Results {#s3}
=======

Of 595 participants enrolled during the study, mean age in this population is 60 years old and majority of the patient is male (71.9%). The most common diagnosis is acute coronary syndrome (69.9%). ST-elevation acute myocardial infarction (STEAMI) was found more frequent compared to acute non-ST-elevation acute myocardial infarction (NSTEAMI) with 69.7% and 30.3%, respectively. Mortality event is found in 55 patients (9.2%) regardless of the etiology ([Table 1](#T1){ref-type="table"}).

###### Baseline Characteristics of the Research Subject

  Parameter                                 N = 595
  ----------------------------------------- ---------------
  Age, year ± SD                            59.92 ± 13.0
  Gender                                    
    Male, n (%)                             428 (71.9)
    Female, n (%)                           167 (28.1)
  Diagnosis                                 
    Arrhythmia^a^, n (%)                    84 (14.1)
    Acute coronary syndrome, n (%)          416 (69.9)
      STEAMI                                290 (69.7)
      NSTEAMI                               126 (30.3)
    Worsening of CHF^b^, n (%)              25 (4.2)
    Peripheral vascular disease^c^, n (%)   22 (3.7)
    Post open heart surgery, n (%)          27 (4.5)
    Others^d^, n (%)                        21 (3.5)
  Comorbid factor                           
    Pneumonia, n (%)                        47 (7.9)
    Hypertension, n (%)                     324 (54.5)
    Diabetes mellitus, n (%)                162 (27.2)
  Mortality, n (%)                          55 (9.2)
  Ventilator utilization, n (%)             33 (5.5)
  Laboratory examination                    
    Hemoglobin, g/dL ± SD                   13.7 ± 7.9
    Thrombocyte, cell/mm^3^ ± SD            251.7 ± 82.3
    Neutrophil, cell/mm^3^ ± SD             76.1 ± 30.0
    Lymphocyte, cell/mm^3^ ± SD             16.8 ± 12.2
    Creatinine, mg/dL ± SD                  2.38 ± 13.8
    Blood sugar, mg/dL ± SD                 164.8 ± 94.0
    SGOT, U/L ± SD                          101.9 ± 313.2
    SGPT, U/L ± SD                          55.2 ± 156.6
  Echocardiography examination              
    Ejection fraction, % ± SD               51.1 ± 13.3
    TAPSE, mm ± SD                          18.2 ± 5.2

^a^Malignant arrhythmias e.g. unstable ventricular tachycardia or supraventricular tachycardia, degenerative process e.g. sinus node dysfunction or AV node dysfunction; ^b^Acute decompensated heart failure whose etiology is valvular heart disease or ischemia heart disease or hypertensive heart disease; ^c^Acute limb ischemia or critical limb ischemia; ^d^Pulmonary embolism, myocarditis and post cardiac arrest syndrome. STEAMI: ST-elevation acute myocardial infarction; NSTEAMI: non-ST-elevation acute myocardial infarction; CHF: chronic heart failure; SGOT: serum glutamic oxaloacetic transaminase; SGPT: serum glutamic pyruvate transaminase; TAPSE: tricuspid annular plane systolic excursion.

Bivariate analysis showed significant difference between some predictors that affecting the mortality event in this study. These are pneumonia, diabetes mellitus, the use of ventilator, hemoglobin level \< 10 g/dL, creatinine level \> 1.5 mg/dL, random blood glucose \> 200 mg/dL, serum glutamic oxaloacetic transaminase (SGOT) and serum glutamic pyruvic transaminase (SGPT) \> 50 U/L, decreased right ventricular function with TAPSE \< 17 mm and left ventricle ejection fraction \< 40% ([Table 2](#T2){ref-type="table"}).

###### Baseline Characteristic of the Research Subject (Survivor versus Non-Survivor)

  Parameter                              Survivor (N = 540)   Non-survivor (N = 55)   P value
  -------------------------------------- -------------------- ----------------------- ------------
  Age, year ± SD                         59.8 ± 12.9          61.3 ± 13.5             
    Age ≥ 60 years, n (%)                284 (52.6)           33 (60)                 0.226
  Gender                                                                              0.789
    Male, n (%)                          428 (71.9)           38 (69.1)               
    Female, n (%)                        167 (28.1)           17 (30.9)               
  Diagnosis                                                                           
    Arrhythmia, n (%)                    82 (15.2)            2 (3.6)                 
    Acute coronary syndrome, n (%)       380 (70.4)           36 (65.5)               0.585
      STEAMI                             265 (69.7)           25 (69.4)               
      NSTEAMI                            115 (30.3)           11 (30.6)               
    Worsening of CHF, n (%)              21 (3.9)             4 (7.3)                 
    Peripheral vascular disease, n (%)   19 (3.5)             3 (5.5)                 
    Post open heart surgery, n (%)       27 (5.0)             \-                      
    Others, n (%)                        11 (2.0)             10 (18.2)               
  Comorbid factor                                                                     
    Pneumonia, n (%)                     29 (5.4)             18 (32.7)               ≤ 0.0001\*
    Hypertension, n (%)                  298 (55.2)           26 (47.3)               0.329
    Diabetes mellitus, n (%)             140 (25.9)           22 (40)                 0.019\*
  Ventilator utilization, n (%)          11 (2.0)             22 (40)                 ≤ 0.0001\*
  Laboratory examination                                                              
    Hemoglobin \< 10 g/dL, n (%)         41 (7.6)             9 (16.4)                0.022\*
    Creatinine \> 1.5 mg/dL, n (%)       153 (28.3)           33 (60)                 0.000\*
    Blood sugar \> 200 mg/dL, n (%)      107 (19.8)           20 (36.4)               0.003\*
    SGOT \> 50 U/L, n (%)                190 (35.2)           33 (60)                 0.001\*
    SGPT \> 50 U/L, n (%)                113 (20.9)           25 (45.5)               ≤ 0.0001\*
  Echocardiography examination                                                        
    Ejection fraction \< 40% ± SD        87 (16.1)            24 (43.6)               ≤ 0.0001\*
    TAPSE \< 17 mm ± SD                  154 (28.5)           30 (54.5)               ≤ 0.0001\*

\*Statistically significant (P \< 0.05).

Multivariate analysis also showed some factors could be independent predictors of mortality, those are age ≥ 60 years old (odds ratio (OR): 1.97), pneumonia (OR: 2.51), the use of mechanical ventilator (OR: 20.98), creatinine level \> 1.5 mg/dL (OR: 2.97), SGPT level \> 50 U/L (OR: 1.42) and an ejection fraction \< 40% (OR: 2.21) ([Table 3](#T3){ref-type="table"}).

###### Multivariate Analysis of Factors Predicting Mortality (N = 595 Patients)

  Parameter                         OR      95% CI           P value
  --------------------------------- ------- ---------------- -------------
  Age ≥ 60 years                    1.97    0.926 - 4.192    0.078\*
  Comorbid pneumonia                2.51    0.992 - 6.37     0.052\*
  Diabetes mellitus                 1.08    0.432 - 2.734    0.86
  Ventilator utilization            20.98   7.672 - 57.406   \< 0.0001\*
  Hemoglobin \< 10 g/dL             1.35    0.456 - 3.997    0.587
  TAPSE \< 17 mm                    1.70    0.837 - 3.468    0.142
  SGOT \> 50 U/L                    1.42    0.604 - 3.339    0.421
  SGPT \> 50 U/L                    1.70    0.704 - 4.107    0.028\*
  Random blood sugar \> 200 mg/dL   1.19    0.465 - 3.037    0.717
  Creatinine \> 1.5 mg/dL           2.97    1.475 - 5.971    0.002\*
  Ejection fraction \< 40%          2.21    1.077 - 4.554    0.031\*

\*Statistically significant (P \< 0.1) after backward stepwise method analysis. OR: odds ratio.

Each of the independent predictors was assessed to create a calculation for CICU scoring system ([Table 4](#T4){ref-type="table"}).

###### Assessment of the Score Value From Each Independent Predictor Factor

  Parameter                  B       SE      B/SE   (B/SE)/x   Score
  -------------------------- ------- ------- ------ ---------- -------
  Age ≥ 60 years             0.678   0.385   1.76   1          1
  Pneumonia                  0.922   0.478   1.92   1.09       1
  Ventilator                 3.061   0.509   6.01   3.41       3
  SGPT \> 50 U/L             0.782   0.356   2.19   1.24       1
  Creatinine \> 1.5 mg/dL    1.088   0.357   3.04   1.73       2
  Ejection fraction \< 40%   0.795   0.368   2.16   1.22       1

The first scoring system model is based on the probability to have mortality event with minimum score of +1 and a maximum score of +9 ([Table 4](#T4){ref-type="table"}).

Regression test was used to form a scoring system based on the probability of mortality event. For example, the probability that the patient would experience mortality is 75.9% if a patient has a total score of 7 ([Table 5](#T5){ref-type="table"}).

###### Scoring System Based on Patient's Probability on Mortality Event

  Score   Probability (%)
  ------- -----------------
  0       1.1
  1       2.4
  2       5.3
  3       11.1
  4       21.8
  5       38.5
  6       58.4
  7       75.9
  8       87.6
  9       94.1

The second scoring system model is based on cut-off point in the ROC curve analysis. The ROC statistical method is derived from trading off between sensitivity and specificity in some alternative cut-off points presented as a graphic ([Fig. 1](#F1){ref-type="fig"}, [Table 6](#T6){ref-type="table"}).

![Sensitivity and specificity graph based on ROC analysis.](cr-10-216-g001){#F1}

###### Sensitivity and Specificity of Each Graphic Point Towards Patient's Probability to Experience Mortality Event

  No   Positive if greater than or equal to   Sensitivity   1 - Specificity   Sensitivity   Specificity
  ---- -------------------------------------- ------------- ----------------- ------------- -------------
  1    -1.0000                                1.000         1.000             1.000         0.000
  2    0.5000                                 1.000         0.749             1.000         0.251
  3    1.5000                                 0.907         0.416             0.907         0.584
  4    2.5000                                 0.796         0.264             0.796         0.736
  5    3.5000                                 0.630         0.098             0.630         0.902
  6    4.5000                                 0.370         0.030             0.370         0.970
  7    5.5000                                 0.278         0.009             0.278         0.991
  8    6.5000                                 0.204         0.007             0.204         0.993
  9    7.5000                                 0.074         0.004             0.074         0.996
  10   8.5000                                 0.019         0.000             0.019         1.000
  11   10.0000                                0.000         0.000             0.000         1.000

From a cut-off analysis between [Figure 1](#F1){ref-type="fig"} and [Table 6](#T6){ref-type="table"}, a cut-off point of 4 was taken. Thus, a score between +3 and +9 has a higher chance to have an outcome of death than a score between +1 and +2. This scoring system has 80% sensitivity with 74% specificity to predict a mortality event.

Discussion {#s4}
==========

This study collected 595 participants from January to October 2017 at CICU of Sardjito General Hospital. During that period, acute coronary syndrome (69.9%) was identified as the most common diagnosis. Of acute coronary syndrome patients, STEAMI was the majority cause (69.7%). Other diagnoses found at CICU are arrhythmia (14.1%), followed by post-heart surgery patient (4.7%), worsening of heart failure (4.2%), peripheral vascular disease (3.7%), and other causes (3.5%).This result looks similar compared to previous study done by Dogan et al \[[@R06]\] who reported that 65% CICU patients was diagnosed by acute coronary syndrome and 43.4% of them was STEAMI. Other study \[[@R07]\] also showed that acute coronary syndrome was the main diagnosis for inpatients in the ICU (57%) with 46.2% STEAMI and 53.7% NSTEAMI. The result was followed by systolic heart failure (6.2%), bradycardia (5.6%), cardiac arrest (4.6%) and atrial fibrillation (3.6%).

Fifty-five patients (9.2%) died during the study and mostly due to cardiogenic and septic shock. Patient mortality rate between previous studies are different (12.7% \[[@R06]\], 5.6% \[[@R07]\], 13% \[[@R08]\] and 7-8% \[[@R9]\]). The leading cause of death is also varied like cardiogenic shock, sepsis and respiratory failure \[[@R07]\].

Some studies have analysed mortality predictor factors which were recorded at patient's entry to CICU such as hypotension, tachycardia, low oxygen saturation, increased blood urea level, blood sugar level, magnesium, liver enzyme, troponin and B-type natriuretic peptide \[[@R07]\]. Our study showed that factors that can work as a predictor of mortality include pneumonia, diabetes mellitus, the use of mechanical ventilator, haemoglobin level \< 10 g/dL, creatinine level \> 1.5 mg/dL, random blood sugar \> 200 mg/dL, SGOT and SGPT level \> 50 U/L, decreased of right ventricular function with TAPSE \< 17 mm and reduced ejection fraction \< 40%.

Multivariate analysis shows factors can act as an independent predictor of mortality, which are age ≥ 60 years (OR: 1.97), presence of pneumonia as comorbid factor (OR: 2.51), mechanical ventilator utilization (OR: 20.98), creatinine level \> 1.5 mg/dL (OR: 2.97), SGPT level \> 50 U/L (OR: 1.42) and also ejection fraction \< 40% (OR: 2.21).

In our study, age ≥ 60 years old is an independent predictor of mortality. The findings of other studies found age as a predictor factor of mortality. There is a significant difference between mean age of the patient that has an outcome of death compare to the other group with better outcome (75 versus 66.9; P \< 0.001) \[[@R07]\]. Studies conducted found that patient with age ≥ 65 years old have a significantly higher mortality risk when treated in the ICU (HR: 1.81 with CI 1.49 - 2.19; P \< 0.001) \[[@R10]\].

Pneumonia is an independent predictor of mortality in our study that has OR of 2.51. Community acquired pneumonia (CAP) is a disease which is closely related to an increase in mortality rate. The mortality rate of CAP in inpatients during the period is 12%, and can reach more than 30% if the patient is treated in the ICU \[[@R11]\]. From a study which take a population of \> 2,000 patient with diagnosis of CAP, 75% of the patient treated in the ward of the hospital with age ≥ 65 years old have a higher mortality compare to younger patient population. Age is an independent risk factor of death in pneumonia patients because an elderly patient usually has a more advance stage of the disease at the time of admission. The clinical symptom of pneumonia in the elderly is not clearly visible, vital sign parameter usually does not show an abnormal result compare to the younger patients. In addition, the doctor and patient's family can overlook pneumonia at early diagnosis \[[@R12]\].

Utilization of mechanical ventilation acts as an independent predictor of mortality in our study with the highest OR associated with mortality event (OR: 20.98). One study which analyse predictor of mortality in the ICU patient also found that utilization of mechanical ventilator correlate with mortality event 11.7% \[[@R07]\]. Other study that assess outcome of patient ≥ 65 years old whom is treated in the ICU, also found that utilization of mechanical ventilator can become an independent predictor of mortality event with HR of 2.74 (CI: 2.00 - 3.76; P \< 0.001) \[[@R10]\]. In another study, from a total of 1,115 ICU patients using a mechanical ventilator, the mortality rate is found to be 51% (564 patients). Further analysis shows that age is one independent predictor of mortality in this study (HR: 1.01 with CI: 1.004 - 1.014; P \< 0.001) \[[@R13]\].

Laboratory examination results that can work as an independent predictor of mortality event in our study is increase in creatinine level \> 1.5 mg/dL (OR: 2.97) and SGPT \> 50 U/L (OR: 1.42). Decrease in renal function is also found to be associated with mortality and can be an independent predictor of mortality in ICU patient using a mechanical ventilator (HR: 1.29 with CI: 1.06 - 1.56; P = 0.011) \[[@R13]\]. Whereas, an increase in transaminase enzyme is found to correlated with a higher chance of mortality in another study, which shows that mean SGOT is higher in non-survivor group compared to survivor group of patient (74.9 U/L versus 460 U/L; P = 0.000), this result is similar to SGPT level (52.8 U/L versus 280.8 U/L; P = 0.000) \[[@R07]\]. But our study found that SGOT is not an independent predictor of mortality although bivariate analysis shows that increase in SGOT \> 50U/L has a significant value with OR of 2.43 (CI: 1.447 - 4.068; P = 0.001). Result from a study which analysed the influence of an increase in enzyme transaminase level to cardiovascular mortality risk from 2,061 subjects aged 50 - 99 years old observed that an increase of SGPT level \> 40 U/L (on male) and SGPT \> 31 U/L (on female) have a higher mortality risk regardless of the etiology of death. In addition, age remains a key factor where the risk is lower in younger subject population (age ≤ 59 years old, HR: 0.46; 95% CI: 0.06 - 3.49), but will increase with age; age 60 - 69 years old (HR: 1.05; 95% CI: 0.53 - 2.07), age 70 - 79 years old (HR: 1.54; 95% CI: 0.81 - 2.93), and age ≥ 80 years old (HR: 3.53; 95% CI: 1.55 - 8.04). Meanwhile, cardiovascular mortality risk also increases with age; age 70 - 79 years old (HR: 3.15; 95% CI: 1.37 - 7.23) and age ≥ 80 years old (HR: 6.86; 95% CI: 2.44 - 19.3). SGPT enzyme has a role as a specific inflammation enzyme in the liver thus an increase in SGPT enzyme level indicated a severe inflammation process that can affect mortality event \[[@R14]\].

Study that evaluated an abnormality in liver function test on 263 patients with critical disease found that the use of mechanical ventilator, hemofiltration and hypotension on the first 48 h correlated with abnormality of SGPT level on the third day. Abnormal SGPT level was associated with an increase in mortality risk in 30 days period (OR: 2.7; CI: 1.2 - 6.0) \[[@R15]\].

We also found that fraction ejection value \< 40% is an independent predictor of mortality with OR of 2.21 (CI: 1.077 - 4.554; P = 0.031). Mortality in heart failure patient based on some studies is inversely related with left ventricle systolic function. Fraction ejection level is considered as the strongest prognosis factor that affecting poor outcome in heart failure patient \[[@R16]\]. Presence of systolic heart failure is a contributing factor to mortality event in another study that takes a 956 patients population treated in the ICU. In that study mortality event was found in 59 patients (6.1%). Systolic heart failure is found more frequently in non-survivor group compared to survivor group (30.5% versus 14.7%; P = 0.001) \[[@R07]\].

Limitations {#s4a}
-----------

This scoring system is still limited to apply to our hospital. Further research is needed to validate this scoring system when applied to CICU at other hospitals.

Conclusions {#s4b}
-----------

The scoring system developed from this study can be utilized to predict mortality event at CICU of Sardjito General Hospital, and showed a favorable sensitivity and specificity result. Factors that work as independent predictor of mortality in this study are age ≥ 60 years old, presence of pneumonia as a comorbid factor, utilization of mechanical ventilation, increase in creatinine level \> 1.5 mg/dL, SGPT \> 50 U/L, and ejection fraction level \< 40%.
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